Lyra therapeutics to present at bank of america securities 2023 healthcare conference

Watertown, mass., may 09, 2023 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of patients with chronic rhinosinusitis (crs), today announced that maria palasis, ph.d., president and chief executive officer, will present at the bank of america securities 2023 healthcare conference on wednesday, may 10, 2023, at 4:35 p.m. pt.
LYRA Ratings Summary
LYRA Quant Ranking